Quarterly ResultJun 4, 2026, 04:31 PM
CooperCompanies Q2 Revenue Up 8% to $1.08B; GAAP EPS Hit by $271.6M Litigation Charge
AI Summary
The Cooper Companies, Inc. announced its fiscal second quarter 2026 results, reporting a revenue increase of 8% to $1.082 billion. However, GAAP diluted EPS was negatively impacted by a significant $271.6 million litigation-related charge stemming from a CooperSurgical product recall, resulting in a GAAP loss per share of $(0.40). Non-GAAP diluted EPS showed strong growth, up 26% to $1.21. The company also updated its full-year financial guidance.
Key Highlights
- CooperCompanies reported Q2 2026 revenue of $1.082 billion, up 8% YoY.
- Q2 2026 GAAP diluted EPS was $(0.40), impacted by a $271.6 million litigation charge.
- Non-GAAP diluted EPS for Q2 2026 was $1.21, up 26% YoY.
- CooperSurgical recorded an $271.6 million net pre-tax charge for litigation related to embryo culture media recall.
- CooperVision revenue reached $723.5 million, up 8% YoY.
- CooperSurgical revenue reached $358.0 million, up 8% YoY.
- Company updated FY2026 revenue guidance to $4.285 - $4.321 billion and non-GAAP diluted EPS to $4.58 - $4.66.
Price Impact
More from COO